Start Scientific, Inc. Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Balance Sheets

In millions of USD, except per-share amounts

	Q4 FY2018 As of Dec 31, 2018	Q3 FY2015 As of Sep 30, 2015	Q2 FY2015 As of Jun 30, 2015	Q1 FY2015 As of Mar 31, 2015	Q4 FY2014 As of Dec 31, 2014	Q1 FY2014 As of Mar 31, 2014	Q2 FY2014 As of Jun 30, 2014	Q3 FY2013 As of Sep 30, 2013	Q2 FY2013 As of Jun 30, 2013	Q1 FY2013 As of Mar 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q3 FY2012 As of Sep 30, 2012	Q2 FY2012 As of Jun 30, 2012	Q1 FY2012 As of Mar 31, 2012	Q4 FY2011 As of Dec 31, 2011	Q2 FY2011 As of Jun 30, 2011
Cash and cash equivalents
Accounts receivable, net
Inventory
Loans receivable
Prepaid assets
Total Current Assets
Working interest in oil leases
TOTAL ASSETS
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities:
Accounts payable
Accrued expenses
Notes payable, current portion
Notes payable - related parties, current portion
Accounts payable and accrued liabilities - related parties
Convertible debenture/notes payable (net of discount of $73,301 and $-0-, respectively)
Accounts payable and accrued - related parties
Convertible notes payable
Notes payable
Notes payable - related parties
Note payable related party
Derivative Liability, Current
Total current liabilities

Total liabilities
Commitments and contingencies
Stockholders' Deficit
Preferred stock, $0.0001 par value; 100 shares authorized, 100 and -0- issued and outstanding, respectively
Common stock, $0.0001 par value; 500,000,000 shares authorized, 9,165,000 and 500,000 shares issued and outstanding, respectively
Preferred Stock, Value
Common Stock, Value
Additional paid-in capital
Deficit accumulated during exploration stage
Accumulated deficit
Total stockholders' deficit

Total liabilities and stockholders' deficit

Comments